Nuveen Asset Management’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-73,506
| Closed | -$184K | – | 3197 |
|
2023
Q1 | $184K | Sell |
73,506
-18,783
| -20% | -$47K | ﹤0.01% | 2999 |
|
2022
Q4 | $780K | Sell |
92,289
-21,505
| -19% | -$182K | ﹤0.01% | 2773 |
|
2022
Q3 | $961K | Buy |
113,794
+2,589
| +2% | +$21.9K | ﹤0.01% | 2771 |
|
2022
Q2 | $940K | Sell |
111,205
-4,177
| -4% | -$35.3K | ﹤0.01% | 2811 |
|
2022
Q1 | $1.23M | Buy |
115,382
+1,228
| +1% | +$13.1K | ﹤0.01% | 2728 |
|
2021
Q4 | $1.47M | Sell |
114,154
-10,929
| -9% | -$141K | ﹤0.01% | 2709 |
|
2021
Q3 | $1.27M | Buy |
125,083
+10,948
| +10% | +$111K | ﹤0.01% | 2890 |
|
2021
Q2 | $1.17M | Buy |
114,135
+66,136
| +138% | +$677K | ﹤0.01% | 2951 |
|
2021
Q1 | $883K | Buy |
47,999
+10,778
| +29% | +$198K | ﹤0.01% | 2933 |
|
2020
Q4 | $1.28M | Buy |
+37,221
| New | +$1.28M | ﹤0.01% | 2719 |
|